130 related articles for article (PubMed ID: 6308067)
1. Effects of a new angiotensin converting enzyme inhibitor, enalapril, in acute and chronic left ventricular failure in dogs.
Leddy CL; Wilen M; Franciosa JA
J Clin Pharmacol; 1983; 23(5-6):189-98. PubMed ID: 6308067
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
[TBL] [Abstract][Full Text] [Related]
3. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
Dunkman WB; Wilen M; Franciosa JA
Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
Fouad FM; Tarazi RC; Bravo EL; Textor SC
Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
[TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
7. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
[TBL] [Abstract][Full Text] [Related]
8. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Nakazawa M; Ishihara T; Takahashi Y; Okuhira M; Imai S
J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
[TBL] [Abstract][Full Text] [Related]
9. Effect of ACE-Inhibition on regional blood flow during acute left ventricular failure in the dog. Preliminary report.
Hall C; Mørkrid L; Kjekshus J
Scand J Urol Nephrol Suppl; 1984; 79():121-4. PubMed ID: 6089310
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
[TBL] [Abstract][Full Text] [Related]
11. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
13. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
Schiffrin EL; Gutkowska J; Thibault G; Genest J
Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
[TBL] [Abstract][Full Text] [Related]
14. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin.
Vaynblat M; Shah HR; Bhaskaran D; Ramdev G; Davis WJ; Cunningham JN; Chiavarelli M
Eur J Heart Fail; 2002 Oct; 4(5):583-6. PubMed ID: 12413500
[TBL] [Abstract][Full Text] [Related]
16. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
17. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
Hall D; Zeitler H; Rudolph W
J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929
[TBL] [Abstract][Full Text] [Related]
18. Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure.
Naganuma F; Kubota S; Hirahara N; Imai K; Kamiyama H; Iizuka T; Imai S; Murata K; Suzuki T
Jpn Circ J; 1994 Jan; 58(1):34-42. PubMed ID: 8139090
[TBL] [Abstract][Full Text] [Related]
19. The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.
Broughton Pipkin F; Wallace CP
Br J Pharmacol; 1986 Mar; 87(3):533-42. PubMed ID: 3026539
[TBL] [Abstract][Full Text] [Related]
20. Clinical and hemodynamic experience with enalapril in congestive heart failure.
Cody RJ
Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
